Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New Business Journal article on Nanologix.
"New BioTechnology Drives Market for NanoLogix
Wednesday, January 29, 2014
By Dan O'Brien
HUBBARD, Ohio -- A biotechnology company based here has employed some of the latest technology and innovation that can, in extreme cases, make the difference between life and death.
NanoLogix Inc. specializes in the manufacture and packaging of Petri plates and diagnostic kits designed to detect threatening bacteria and other microorganisms more rapidly than traditional Petri culture technology, says its CEO, Bret Barnhizer.
"The Petri plates are our main items of sales right now," Barnhizer reports. "We're also working on the development of other diagnostic kits." The company manufactures 13 types of Petri plates and plans to add more, he says.
Barnhizer says two major innovations distinguish the company's products from others. One plate in particular, the Bio Nano Pore, or BNP, product uses a membrane sandwiched between two layers of agar that scientists use to grow bacteria samples.
Traditionally, samples are detected in Petri plates once they become visible, Barnhizer says. However, the membrane in the BNP plate acts as a platform that, after a given number of hours. is removed.
Once removed, the membrane is placed on a staining plate, he explains. The chemical on that plate then stains the membrane, revealing micro-colonies of bacteria or other organisms invisible through the standard method. "These are miniature versions of what you'd see on a standard plate,” Barnhizer notes.
Thus, the nature of the bacteria or specimen is identified much earlier than the traditional method.
The time needed to detect whether a person is infected by anthrax, for example, takes about six hours using the BNP method, where the standard procedure could take as long as 24 hours, Barnhizer reports.
"That could be the difference between whether someone lives or dies," he comments.
The second method his company pioneered is how the Petri plates are packaged, Barnhizer says.
Most companies in the field package their products by stacking Petri dishes atop one another and sliding them into a plastic sleeve that, on average, holds 10 at a time. Barnhizer patented a method in which the small dishes are stacked two-high in a flat, vacuum pack.
The result is that these Petri plates have a much longer shelf life than those shipped and packaged by standard means. Tests have found that the products packed this way have held their shelf life for two years when stored in cold temperatures, one year in room temperature.
Moreover, Barnhizer says, the packaging method the company uses greatly reduces the risk of the Petri plates breaking or being damaged in shipment.
Seven years ago, Barnhizer began transforming a mostly vacant pole building, once a kitchen and bathroom supply company at 843 N. Main St. in Hubbard, into a sleek laboratory and clean room.
Renovations to the building cost roughly $150,000, while another $300,000 was spent on buying new equipment.
In the clean room, all employees are required to wear coveralls, masks and gloves, as a sophisticated filtering system removes any foreign particles.
In the clean room, the company takes agar, that is, the substance analysts use to grow sample cultures, in a powder form and mixes it until it's liquid. The agar is then transferred into the Petri dishes via a hose pre-programmed to distribute 23 milliliters of the substance onto each plate, which are sealed from the top and bottom.
As the agar sets, it hardens to a gel. The plates are then vacuum-packaged and shipped out.
NanoLogix manufacturers "a few thousand" of these plates per day at its eight workstations, Barnhizer reports.
The CEO relates that the company has secured business with the U.S. Environmental Protection Agency and many other high-profile clients that he's not at liberty to identify. "We recently signed an agreement with a northeast Ohio grocery chain" to monitor food quality, he reports. "Large research labs are buying it, and different universities."
And, the company has been involved in at least six classified projects, Barnhizer says.
NanoLogix recently signed an international distribution agreement with Nasaem Al-Jazira Inc., headquartered in Riyadh, Saudi Arabia. The project was helped through the State of Ohio International Trade Assistance Center at Youngstown State University.
Barnhizer made a request to Gov. John Kasich's office before Christmas and inquired about help through the International Trade Assistance Center and its local representative, Mousa Kassis. The first year of sales of the five-year agreement is expected to yield about $900,000.
"They helped quite a bit," he says about ITAC. "I believe we'll be bringing an intern on from YSU during the summer through the program that ITAC sponsors."
NanoLogix, which employs 12, also distributes its products to other countries. "We've sold to Turkey, Europe, Mexico, Kuwait, Thailand and Singapore," Barnhizer reports."
Copyright 2013 The Business Journal, Youngstown, Ohio.
FYI. I just went to the website. No problem with access.
It was nice to actually see the BNP kit being used in a demonstration.
A quiet morning so far.
I think that I saw the PR on the main page of the Nanologix website two days ago under Nanologix News.
I suppose that a person interested in a job in the Hubbard area could consider sending a resume and cover letter to debby@nanologix.com. That is the only bit of information told to me yesterday that I did not include in my original post.
A family member was at Youngstown State University earlier today and called to let me know that he'd seen some flyers at one of the science buildings advertising for cleanroom Biotech Production/Manufacturing Personnel for Nanologix. He said that there are full and part-time jobs available for workweek and weekend shifts at $11.00 per hour. My take on this is that they must be making some solid progress since they need production people. Very good to see.
I came across this Nanologix v. Novak lawsuit filed last week in Ohio in Federal Court. Anyone know anything about it? I believe that interested parties can access the particulars through a site known as PACER (Public Access to Court Electronic Records), but there appears to be a small charge per page accessed. If I can find further information I will post it.
Nanologix, Inc. v. Novak
More Sharing ServicesShare | Share on googlebuzzShare on emailPlaintiff: Nanologix, Inc.
Defendant: Christopher Novak
Case Number: 4:2013cv01000
Filed: May 2, 2013
Court: Ohio Northern District Court
Office: Youngstown Office
County: Trumbull
Presiding Judge: Sara Lioi
Nature of Suit: Contract - Other Contract
Cause: 28:1332
Jurisdiction: Diversity
Jury Demanded By: Plaintiff
A friend of mine invested in a Nanologix PIPE four or five years ago. I seem to recall him telling me that the CEO, Bret Barnhizer, intended to have investors sign confidentially agreements relating to company activities. I only mention this because I recall that my friend mentioned that these agreements were similar to what employees of Nanologix had to sign. Don't most confidentiality agreements cover ex-employees for a certain period of time -- perhaps as long as one or two years?
Regarding the Board of Directors -- I work in the public sector and have supervised the creation and operation of several boards over the past 20+ years. When board meetings are not held on a regular basis the board members themselves continue to serve until such time as they resign, are removed from office or their successors are elected to replace them. My educated guess is that the Nanologix Board of Directors operates in the same fashion. Lack of a meeting would not, in my opinion, dissolve the board.
Agreed.
N-Assay Multiwell Diagnostic Test? Just noticed this a moment ago -- From the Nanologix Website:
"April 05, 2013:
NanoLogix plans to begin marketing this summer of their new N-Assay Multiwell Diagnostic test. The N-Assay is a machine-readable test that will be available in an assortment of size configurations for detection and identification of a variety of bacteria. Tests to date have provided consistent results in as little as 30 minutes with both high sensitivity and specificity."
I must agree with Parents on this since we are talking about Machiavelli, not Nostradamus.
In my opinion either path would be fine for the short term, although we would all rather see the company be able to pay for whatever expansion would be needed through company sales/profits.
Informative and very disturbing at the same time. XDR TB could, in my opinion, usher in the return of those bad old days where 1 in 4 or 1 in 5 deaths was attributable to what was then called consumption. It is an ugly scenario. International efforts to monitor/control the spread of this and other pathogens do not put me at ease.
You are welcome.
If, by saying that they are one and the same, you mean that their thoughts and opinions on the company are quite similar, then yes, I could agree with you to that extent. If you mean that there is only one person posting under both message board IDs then I would say that you are mistaken. That is all.
Incorrect assumption on your part.
Parents,
I must agree with your comments. Machiavelli10's post shows that he or she has spent a significant amount of time considering the many forces at play with this little company. Very nicely said.
Best Regards,
NEOhioinvestor
Can't help there. No idea.
-- ttboy, the Test Results table in the information section has been corrected/updated.
Very good information to include.
I don't know if this will be an active link or not. If not, just go to the EPA website and type the word Nanologix in the Advanced Search box. The update is the first of 3 items listed.
http://www.epa.gov/nerl/features/nanologix.html
Let me see if that can be done.
Some new information on EPA-Nanologix cooperative activities from the EPA website.
"EPA scientists collaborate in development of rapid methods to identify and measure specific pathogens in drinking water
EPA microbiology scientists are working with NanoLogix, Inc. — a U.S.-based company specializing in live-cell rapid diagnostics — to develop new, rapid, sensitive cost-effective methods for detecting and identifying protozoan and bacterial pathogens in drinking water systems. Such methods would be used by epidemiologists to investigating drinking water pathogen outbreaks.
Current culture-based methods, used to identify and measure specific pathogens during an outbreak, can take up to 2 to 3 days to get results. These new methods would be especially helpful in detecting Cryptosporidium and also E. coli O157:H7 — a strain that can cause serious diarrhea.
The microbiologists are collaborating to improve recoveries of Crypotosporidium oocysts in source waters that feed drinking water systems. They’re using a new immunomagnetic separation procedure being developed by NanoLogix. Increasing recovery rates and establishing greater consistency in results over time can allow more accurate quantification of Cryptosporidium oocysts, which can provide more reliable scientific information on which to base water treatment decisions. This research is part of a Cooperative Research and Development Agreement signed in July 2010.
Currently, EPA and NanoLogix scientists are entering the second phase of research in which scientists are seeking to improve recoveries of E. coli O157:H7 from source water using the same immunomagnetic separation technology, followed by growth on a solid medium using the company’s patented membrane procedure. This procedure promotes rapid growth of bacterial pathogens, due to the increased permeability of the patented filters.
The scientists expect that the membrane procedure will enable them to identify their strain of E. coli more rapidly than current methods allow. Improved recoveries and rapid identification of this type of E. coli will provide scientists with more accurate data on the occurrence of these organisms in drinking water sources, and will enhance EPA’s ability to conduct quantitative microbial risk assessments.
“We believe we will be able to come up with a method for E. coli O157:H7 that will allow us to skip the enrichment step and reduce detection time to less than 24 hours,” said EPA microbiologist Dr. Gerard Stelma. “Eliminating the enrichment step will also make the method more quantitative.”
“In the near future, we would like to have a couple of papers ready for publication, as well as a complete method for the environmental community to use,” Stelma said. “Due to the promising results we have seen thus far, it is possible that we may have more than one method available.” ".
It sounds like very good news from the company. Just hasn't yet translated into a higher share price.
Thank you for sharing your thoughts with us on this message board. Very clear and well written.
Not the moderators. Message likely removed by IH Administrators who determined that the content did not conform with the Terms of Service for the website.
Parents...that is odd. It may be that the loss of the MB is only temporary, although it won't bother me in the slightest if it is gone permanently...
NEO
Wow. Very strange to see that the Yahoo message board has gone by the wayside. My cable modem died last week and was just replaced a few moments ago. I believe that I was going through a period of withdrawal. Did Yahoo just eliminate MBs for pinksheet stocks or was it something else? Anyone have any ideas?
I guess that today's trading session for Nanologix must equal the flattest one we've ever seen. My thinking is that there are many patient shareholders quietly waiting for the next event to unfold, whatever that might be...
The information sounds very positive. One of the seemingly small but necessary steps needed to move the company forward.
Milestones are good, even when they're quiet ones. I look forward to reading the results of the completed clinical study once that information is published in a peer-reviewed medical science journal. I wonder what the timeframe is for the submission of the study results to the FDA, CDC and the WHO.
That is my impression as well.
Just another one of those amazingly quiet trading days for Nanologix.
It will be interesting to see what sorts of contacts Nanologix makes at the Food Safety Summit in Washington, D.C.
Hmmm, still a fairly quiet sort of trading day with Nanologix.
New tests results in for Bubonic Plague and Cholera. Check them out on Nanolgix website in Test Results table.
O.K. everybody. Just keep it nice. No name calling or insults. Disagree all you want but do it in a civil fashion.
Dear Parents,
We appear to be Co-Moderators now according to the website. Don't know why that took place. I just updated the test results table as you requested. I will add further updates as time allows.
Take care.
NEOhio